Cargando…

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways

MicroRNAs (miRNAs) are attractive therapeutic targets for various therapy-resistant tumors. However, the association between miRNA and BRAF inhibitor resistance in melanoma remains to be elucidated. We used microarray analysis to comprehensively study the miRNA expression profiling of vemurafenib re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaoyan, Li, Jun, Sun, Yanhong, Zhang, Yi, Dong, Liyun, Shen, Chen, Yang, Liu, Yang, Ming, Li, Yan, Shen, Guanxin, Tu, Yating, Tao, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288205/ https://www.ncbi.nlm.nih.gov/pubmed/27448964 http://dx.doi.org/10.18632/oncotarget.10669

Ejemplares similares

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
por: HAN, JING, et al.
Publicado: (2016)

Melanoma: BRAFi Rechallenge
por: Kosmidis, Christoforos S., et al.
Publicado: (2023)

The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma
por: Paris, Anaïs, et al.
Publicado: (2022)

CRAF R391W is a melanoma driver oncogene
por: Atefi, Mohammad, et al.
Publicado: (2016)

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma
por: Stark, Mitchell S., et al.
Publicado: (2015)

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2
por: Wang, Penglei, et al.
Publicado: (2023)

miR-365 inhibits duck myoblast proliferation by targeting IGF-I via PI3K/Akt pathway
por: Sun, Wenqiang, et al.
Publicado: (2019)

CircRILPL1 promotes muscle proliferation and differentiation via binding miR-145 to activate IGF1R/PI3K/AKT pathway
por: Shen, Xuemei, et al.
Publicado: (2021)

Selective CRAF Inhibition Elicits Transactivation
por: Morgan, Charles W., et al.
Publicado: (2021)

CircDiaph3 influences PASMC apoptosis by regulating PI3K/AKT/mTOR pathway through IGF1R
por: Liu, Ge, et al.
Publicado: (2023)

Molecular Imaging of IGF-1R in Cancer
por: Sun, Yingying, et al.
Publicado: (2017)

Proteomics and Phosphoproteomics Profiling of Drug-Addicted BRAFi-Resistant Melanoma Cells
por: Li, Bohui, et al.
Publicado: (2021)

Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015)

Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells
por: Reddi, Kiran Kumar, et al.
Publicado: (2022)

Progerin modulates the IGF-1R/Akt signaling involved in aging
por: Jiang, Bo, et al.
Publicado: (2022)

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
por: Gallardo, A, et al.
Publicado: (2012)

Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky
por: NIITSU, Yoshiro, et al.
Publicado: (2022)

Harnessing host innate immunity may combat acquired resistance to BRAFi
por: Tan, Thomas, et al.
Publicado: (2014)

miR-100 inhibits the migration and invasion of nasopharyngeal carcinoma by targeting IGF1R
por: Sun, Xiaoyan, et al.
Publicado: (2018)

Calycosin Suppresses Breast Cancer Cell Growth via ERβ-Dependent Regulation of IGF-1R, p38 MAPK and PI3K/Akt Pathways
por: Chen, Jian, et al.
Publicado: (2014)

Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells
por: Shin, Miyoung, et al.
Publicado: (2015)

MicroRNA-153-3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways
por: Guo, Long, et al.
Publicado: (2021)

miR-181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma
por: Tang, Dong, et al.
Publicado: (2020)

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
por: Krayem, Mohammad, et al.
Publicado: (2018)

Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
por: Fratangelo, Federica, et al.
Publicado: (2018)

BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma
por: Gebhardt, Kathleen, et al.
Publicado: (2021)

Deguelin Induces Apoptosis by Targeting Both EGFR-Akt and IGF1R-Akt Pathways in Head and Neck Squamous Cell Cancer Cell Lines
por: Baba, Yuh, et al.
Publicado: (2015)

Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis
por: Zhang, Runze, et al.
Publicado: (2021)

miR-9-5p Inhibits Skeletal Muscle Satellite Cell Proliferation and Differentiation by Targeting IGF2BP3 through the IGF2-PI3K/Akt Signaling Pathway
por: Yin, Huadong, et al.
Publicado: (2020)

CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway
por: Wang, Yu, et al.
Publicado: (2020)

A MEK-independent role for CRAF in mitosis and tumor progression
por: Mielgo, Ainhoa, et al.
Publicado: (2011)

The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma
por: Thompson, Elizabeth L., et al.
Publicado: (2021)

Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
por: Aleksic, Tamara, et al.
Publicado: (2016)

IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma
por: Gao, Ling, et al.
Publicado: (2014)

SMO Regulates IGF1R levels and AKT Localization and Signaling
por: Agarwal, Nitin K, et al.
Publicado: (2022)

DAB2 promotes pulmonary fibrosis and may act as an intermediate between IGF‑1R and PI3K/AKT signaling pathways
por: Liang, Chun-Lian, et al.
Publicado: (2023)

Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
por: Jaiswal, Bijay S., et al.
Publicado: (2009)

Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
por: Chang, Hua-Pin, et al.
Publicado: (2018)

Circular RNA TTN Acts As a miR-432 Sponge to Facilitate Proliferation and Differentiation of Myoblasts via the IGF2/PI3K/AKT Signaling Pathway
por: Wang, Xiaogang, et al.
Publicado: (2019)

Potential Use of Anti-Cancer Drugs for Treatment of Preeclampsia by Targeting the miRNA-IGF1R-PI3K-AKT Axis
por: Li, Jieyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ppc2hak6cv6tmav8p8lkokpr76